Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
The Neurologist|November 3, 2011
Continuous dopaminergic stimulation: clinical aspects and experimental basesMaria Cruz Rodriguez-Oroz, Concepción Marin, Oriol de FabreguesParkinson'S Disease|December 6, 2018
Sleep Quality and Levodopa Intestinal Gel Infusion in Parkinson's Disease: A Pilot StudyOriol De Fabregues, Alex Ferré, Odile Romero, et al.Brain and Behavior|March 24, 2020
Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case seriesOriol De Fabregues, Jaume Viñas, Antoni Palasí, et al.Journal of Neurology|January 25, 2012
Polyneuropathy while on duodenal levodopa infusion in Parkinson's disease patients: we must be alertDiego Santos-García, Raúl de la Fuente-Fernández, Francesc Valldeoriola, et al.Clinical Nuclear Medicine|March 28, 2013
Progressive presynaptic dopaminergic deterioration in Huntington disease: a [123I]-FP-CIT SPECT two-year follow-up studyJosep Gamez, Carles Lorenzo-Bosquet, Gemma Cuberas-Borrós, et al.Sleep Medicine|September 24, 2025
Temporal distribution of electromyographic activity and behaviors in REM sleep in patients with isolated REM sleep behavior disorderNathalie Mariño, Mónica Serradell, Gerard Mayà, et al.Advances in Therapy|June 21, 2017
An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease PatientsRejko Krüger, Paul Lingor, Triantafyllos Doskas, et al.Parkinsonism & Related Disorders|May 25, 2015
Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registryMaríateresa Buongiorno, Francesca Antonelli, Ana Cámara, et al.Brain and Behavior|August 23, 2017
Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusionOriol De Fabregues, Joan Dot, Monder Abu-Suboh, et al.Parkinsonism & Related Disorders|August 26, 2015
Clinical and imaging markers in premotor LRRK2 G2019S mutation carriersDolores Vilas, Lourdes Ispierto, Ramiro Álvarez, et al.Pageof 2